CAL
MBIO icon

Capital Advisors Ltd’s Mustang Bio MBIO Stock Holding History

Capital Advisors Ltd’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21
Closed -$1K – 1520
2024
Q2 		$1K Buy
21
+19
+950% +$361 ﹤0.01% 1233
2024
Q1 		$0 Buy
+2
New +$127 ﹤0.01% 1478

Other funds holding MBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Advisors Ltd's MBIO Position: Q3 2024 in Review

Capital Advisors Ltd sold out of Mustang Bio (MBIO) in Q3 2024, closing a stake of 21 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in MBIO in Q1 2024 and held it in 2 quarters. The position peaked at $1K in Q2 2024. 25 funds tracked by Wall St. Rank hold MBIO as of Q3 2024.

  • Capital Advisors Ltd reported no remaining Mustang Bio position as of Q3 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 21 Mustang Bio shares in Q3 2024, an estimated $1K.
  • Capital Advisors Ltd first reported a position in Mustang Bio in Q1 2024 and held it in 2 quarters.
  • Capital Advisors Ltd's Mustang Bio position peaked at $1K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2024.

Based on Capital Advisors Ltd's 13F filing for Q3 2024, filed 24 Oct 2024.